Chiesi USA, Inc. · 17 hours ago
Intern, Strategic Innovation - Summer 2026
Chiesi USA, Inc. is an international research-focused biopharmaceutical group dedicated to promoting a healthier world. They are seeking an intern for their Strategic Innovation team to support the evaluation of innovative therapeutic modalities for rare diseases.
BiotechnologyMedicalPharmaceutical
Responsibilities
Scout and screen relevant scientific information on new therapeutic opportunities for rare diseases and share findings with the team
Document data in clustered spread sheets and constantly update them as new information becomes available
Present data for review, group discussions, and team meetings
Actively participate in recurring meetings with Strategic Innovation Unit team
Qualification
Required
Currently pursuing a BS/BA in Chemistry, Pharmacy, or Biologic Sciences with an expected graduation date of Fall 2026 or later
Scientific research experience preferred
Proficiency in reading, interpreting, and evaluating scientific data
Demonstrated proficiency in written, verbal, and face-to-face communication to effectively present information to and influence decision making of managers
Ability to successfully manage multiple tasks and multifunctional resources concurrently while maintaining high attention to detail while responding to rapidly changing priorities and aggressive deadlines
Proficient in MS Office (Word, Excel, Project) and Adobe
Preferred
Scientific research experience preferred
Company
Chiesi USA, Inc.
Chiesi USA is a pharmaceuticals company specializing in pharmaceutical research & development services.
H1B Sponsorship
Chiesi USA, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2022 (1)
2021 (1)
Funding
Current Stage
Growth StageTotal Funding
$0MKey Investors
North Carolina Biotechnology Center
2020-08-04Grant· $0M
Leadership Team
Recent News
Clinical Trials Arena
2024-05-24
Company data provided by crunchbase